The Patent Finder

Cell Genesys, Inc.

Also on record
Records under this name other than patents Cell Genesys, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Cell Genesys, Inc.

PatentTitleStatus Expires Confidence
US 7,919,079Cancer Immunotherapy Compositions and Methods of Use
Formerly held
In force
 · High confidence
In forceHigh confidence
US 7,870,581Signal processing apparatus and methods
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,901,902Methods and Compositions for Identifying a Cellular Immune Response Against Prostate Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 9,669,081Methods and Compositions for Treating Prostate Cancer or Inducing a Humoral Immune Response Against Prostate Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,497,781Methods of treating bladder cancer by combination therapy comprising the oncolytic adenovirus CG0070 and an immune checkpoint inhibitor
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 12,090,183Methods of treating solid or lymphatic tumors by combination therapy
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,840,881Methods and Compositions for Treating Prostate Cancer or Inducing a Humoral Immune Response Against Prostate Cancer
Formerly held
Lapsed on the fee record
Ended Sep 23, 2026 · High confidence
Lapsed on the fee recordEnded Sep 23, 2026High confidence
US 7,473,418Pan cancer oncolytic vectors and methods of use thereof
Formerly held
Term ended
Term ended Mar 9, 2025 · From the USPTO record
Term endedTerm ended Mar 9, 2025From the USPTO record
US 7,858,083Pan Cancer Oncolytic Vectors and Methods of Use Thereof
Formerly held
Term ended
Ended no later than Mar 9, 2025 · Low confidence
Term endedEnded no later than Mar 9, 2025Low confidence
US 7,176,022Directly injectable formulations which provide enhanced cryoprotection of cell products
Formerly held
Term ended
Term ended Feb 27, 2024 · From the USPTO record
Term endedTerm ended Feb 27, 2024From the USPTO record
10 of 137 patents shown.
Pro members see all 137.
Pro members: see all 137 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited